FerGene Stock

www.fergene.comHealthcareFounded: 2019

FerGene is a gene therapy company dedicated to creating and delivering innovative solutions for bladder cancer. The company's goal is to harness the promise of gene therapy to develop a novel treatment for non-muscle invasive bladder cancer.

Register for Details

For more details on financing and valuation for FerGene, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for FerGene.

Register Today

Other companies like FerGene in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B